New

RapidAI

The AI engine Fit Assessment

Beta

RapidAI clearly operates at the intersection of AI technology and healthcare, delivering AI-powered clinical imaging and workflow solutions for hospitals worldwide.

Blurb

RapidAI empowers clinicians to make accurate diagnostic and treatment decisions for stroke and aneurysm patients.

HQ Location

San Mateo (United States)

Founded

2011

Employees

51 - 200

Total funding raised

$100.00M

Funding Status

Series C, $75.00M, July 27, 2023

RapidAI is the trusted leader in deep clinical AI, helping hospitals deliver faster, more informed care through intelligent imaging and integrated workflows. The Rapid Enterprise™ Platform supports disease states across the care spectrum, but it’s our clinical depth that drives the most meaningful impact — improving decision-making, patient outcomes, and health-system performance.



Used by more than 2,500 hospitals in over 100 countries and backed by 700+ clinical studies, including research that helped expand national stroke-treatment guidelines, RapidAI is the most clinically validated AI platform in healthcare.



Discover the value of clinical depth at scale at rapidai.com.